
Jan 9 (Reuters) - Edwards Lifesciences Corp EW.N:
EDWARDS COMMENTS ON JENAVALVE ACQUISITION
EDWARDS LIFESCIENCES CORP - REVISES 2026 EPS GUIDANCE TO $2.90-$3.05
EDWARDS LIFESCIENCES CORP - FTC BLOCKS EDWARDS' ACQUISITION OF JENAVALVE
EDWARDS LIFESCIENCES CORP: EDWARDS WILL NOT ACQUIRE JENAVALVE